Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
02/2006
02/15/2006CN1733071A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process
02/15/2006CN1733070A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process
02/15/2006CN1733069A Oral cavity spray containing two effective parts of compound red sage root formula and its preparation process
02/15/2006CN1733068A Chinese medicinal preparation for promoting blood circulation, dissipating blood stasis, inducing reuscitation with aromatics and preparation process thereof
02/15/2006CN1733066A Medicinal composition containing red sage root extract and its application in preparation of medicine for preventing or treating cardiovascular and cerebrovascular disease
02/15/2006CN1733064A Pain stopping ointment for piles
02/15/2006CN1733061A Chinese medicinal preparation with astragalus root and erigeron breviscapus and application thereof
02/15/2006CN1733060A Usage of asiabell and astragalus root composition in decrease of platelet aggregation
02/15/2006CN1733059A Cardiovascular and cerebrovascular disease treating medicine
02/15/2006CN1733049A Soft capsule for treating heart palpitation and its preparation method
02/15/2006CN1733046A Externally used medicine bag for treating piles and preparation method thereof
02/15/2006CN1733039A Compound preparation of breviscapinum for treating cardiovascular and cerebrovascular diseases and its preparing process
02/15/2006CN1733037A Chinese medicinal preparation for treating cardiovascular diseases and its preparing process
02/15/2006CN1733036A Dripping pills for dredging thrombus and preparation process thereof
02/15/2006CN1733031A Brain caring oral liquid and its preparation process
02/15/2006CN1733030A Chest discomfort treating oral liquid and preparation process thereof
02/15/2006CN1733029A Chinese medicinal composition with bilateral functions for treating angina pectoris and/or arrhythmia
02/15/2006CN1733023A Red rice and gingko leaf composition for preventing and treating cardiovascular and cerebrovascular disease and its application
02/15/2006CN1733019A Medicine for treating cardiovascular and cerebrovascular disease
02/15/2006CN1733013A Novel route for administering hairy holly injection and preparation process thereof
02/15/2006CN1732994A Medical caring product for piles and preparation process thereof
02/15/2006CN1732989A Miao ethnic medicine for treating piles and its preparing process
02/15/2006CN1732974A Medicinal composition of fructose diphosphate sodium and magnesium salt
02/15/2006CN1732972A Dextran for injection and method for preparing the same
02/15/2006CN1732970A Breviscapine injection liquid and its preparing process
02/15/2006CN1732966A Dispersible tablet of puerarin and its preparation process
02/15/2006CN1732964A Pharmaceutical composition, its preparation process and usage
02/15/2006CN1732954A Freeze dry emulsion of prostaglandin for injection and method for preparing the same
02/15/2006CN1732953A Dispersible tablet for treating hypertension
02/15/2006CN1732952A Compound dispersible tablet for treating hypertension
02/15/2006CN1732936A Nimodipine emulsion injection liquid and method for preparing the same
02/15/2006CN1732935A Compound orally administered formulation of Carvedilol and manidipine
02/15/2006CN1732934A Freeze dry betahistine hydrochloride injection and method for preparing the same
02/15/2006CN1732923A Ligustilide cyclodextrin or its derivatives clathrate, its preparation method and pharmaceutical formulation
02/15/2006CN1732921A Application of ligustilide in preparation of medicine for preventing and treating cerebral ischemia diseases
02/15/2006CN1732915A Tanshinone IIA infusion solution and its preparation method
02/15/2006CN1732913A Propylgallate injection liquid with favorable stability and its preparation process
02/15/2006CN1732908A Borneol contained spray
02/15/2006CN1732904A Externally applied powder
02/15/2006CN1241932C Novel oligosaccharides, preparation method and pharmaceutical composition containing same
02/15/2006CN1241921C Fluoro isoflavone containing derivative, monufacturing method and its use
02/15/2006CN1241915C Prepn process and use of substituted pyrazole compound
02/15/2006CN1241909C Carboxylic acid derivatives as IP antagonists
02/15/2006CN1241901C Perfluoronated cycle-containing tertiary amines used as basis for gas-conveying emulsions and preparation method
02/15/2006CN1241632C Chinese patent medicine for treating cardiac function failure and its preparation method
02/15/2006CN1241612C Medicine for treating paralysis disease
02/15/2006CN1241611C Medicine for treating hypertension and its preparing process
02/15/2006CN1241602C Oral administered medicated wine for treating cardiovascular and cerebrovascular diseases
02/15/2006CN1241593C Compound of Chinese traditional medicine in use for acute stage of apoplexy of cerebral cerebral ischemia
02/15/2006CN1241592C Medicinal liquor for bringing high blood pressure down and preparing process thereof
02/15/2006CN1241588C Fructus choerospondiatis freeze-drying powder injection and its preparing method
02/15/2006CN1241584C Chinese proprietary medicine for treating coronary heart disease and angina pectoris
02/15/2006CN1241583C Fermented soybean extracted liquid and composite medicine containing the said liquid
02/15/2006CN1241577C Medicine use of cyclodextrin derivatives and medicine composition thereof
02/15/2006CN1241575C Cell growth regulating factor U and its preparation process
02/15/2006CN1241566C Cilostazol solid dispersion and its method for preparing tablet
02/15/2006CN1241563C Application of Jigansan extract in preparation of medicine for treating angiocardiopathy
02/15/2006CN1241558C Atenolol guttate pill and method for preparing the same
02/15/2006CN1241554C Medicinal composition for treating hypertension and preparing method thereof
02/14/2006US6998503 crystallized as an anhydrous, stoichiometric 1.5 HCl salt; inhibiting or modulating nitric oxide synthesis
02/14/2006US6998416 Cyclic AMP-specific phosphodiesterase inhibitors
02/14/2006US6998412 Heterocyclic compounds
02/14/2006US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic
02/14/2006US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease
02/14/2006US6998405 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
02/14/2006US6998401 Such as 2-(4-amino-2,3,5-trimethylphenoxy)-N-methyl-N-(4-piperidinyl)acetamide which has neuroprotective effects by inducing calcium binding proteins
02/14/2006US6998398 use in improvement of gastrointestinal blood flow, in treatment of hypertension and in treatment and prophylaxis of cardiac damages induced by adriamycin and comparable anti-cancer drugs
02/14/2006US6998395 Controlled release formulation for preventing or treating risk factors for cardiovascular disease
02/14/2006US6998263 Methods of preparing and using a viral vector library
02/14/2006US6998254 Use of ROR for receptors for screening substances useful for the treatment of atherosclerosis
02/14/2006US6998107 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography
02/14/2006US6997865 Cardiac support device with anti-fibrosis lining
02/14/2006US6997863 Thermotherapy via targeted delivery of nanoscale magnetic particles
02/14/2006CA2450740C Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
02/14/2006CA2375385C Propargyl phenyl ether a2a receptor agonists
02/14/2006CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists
02/14/2006CA2363145C Oxamic acids and derivatives as thyroid receptor ligands
02/14/2006CA2209825C Heterocyclic-fused pyridines
02/11/2006CA2515754A1 Kit for dip coating medical devices comprising an aqueous latex polymeric emulsion
02/09/2006WO2006015124A2 Fused ring heterocycle kinase modulators
02/09/2006WO2006014864A2 Methods and compositions for reducing c-reactive protein
02/09/2006WO2006014005A1 Pyrazole derivative
02/09/2006WO2006013948A1 Triazole derivative
02/09/2006WO2002088316A3 G-protein coupled receptors
02/09/2006US20060031956 Nucleotide sequences for gene regulation and methods of use thereof
02/09/2006US20060030618 Vanilloid receptor ligands and their use in treatments
02/09/2006US20060030614 dissolving in a solvent, precipitating crystal form by cooling the solution to about -20C
02/09/2006US20060030605 Pharmaceutical compounds
02/09/2006US20060030598 Thiazolyl inhibitors of Tec family tyrosine kinases
02/09/2006US20060030580 Contacting phenolic piperidines with opioid receptors; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction
02/09/2006US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
02/09/2006US20060030573 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes
02/09/2006US20060030568 Crystal modificaion of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use
02/09/2006US20060030561 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma
02/09/2006US20060030557 Substituted pyridines having antiangiogenic activity
02/09/2006US20060030005 C3b/C4b complement receptor-like molecules and uses thereof
02/09/2006US20060030004 Solid phase synthesis
02/09/2006US20060029990 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity
02/09/2006US20060029605 Use of ErbB receptor ligands in treating diabetes
02/09/2006US20060029592 Methods of treating peripheral arterial occlusions